Milan to host CPHI Worldwide return in 2021

2021 will bring global pharma community back together, in person, to drive business growth.

The event returns as the pharma industry in Italy is anticipated to be a major beneficiary of geo-diverse sourcing strategies.

Italy is Europe’s largest producer and exporter of APIs — 85% are exported to North America, the EU and Japan — and the 2020 CPHI Annual Report Survey indicates the country is well set for growth in 2021, as pharma looks for new manufacturing partners.

The report's results show that Italy has improved its ‘growth ranking’ by 16% in a year — the largest rise of any country — with Western European API manufacturers predicted to be the ‘biggest beneficiaries of supply chain changes’ by some 47% of respondents.

To further empower the industry’s growth, CPHI Worldwide 2021 will implement a ‘hybrid event model’, featuring onsite exhibition and conference agenda, as well as online sessions and matchmaking.

Offering further encouragement for the prospects of attendees, nearly two thirds (61%) of the industry foresees an improved ‘business outlook for pharma’ in 2021, with 67% ‘actively looking for new partners’.

Orhan Caglayan, Brand Director at CPHI Worldwide/Informa said the event next year will be "so important, as it will be the first time the global community has come back together.”

CPHI Worldwide 2021 in Milan will feature all five co-located events; including P-MEC, FDF, ICSE, BioProduction and Innopack, with Informa’s AllSecure Standards implemented, providing the most robust at-event biosafety measures, spanning dozens of special health and safety protocols.

Caglayan said: “Over the last 30+ years we have built a platform to unite the specialist communities improving healthcare, and our role has never been more important as new supply chain partnerships are sought globally. We help accelerate pharma advancement by enabling attendees to meet with not just one or two, but hundreds of potential partners simultaneously.”